Загрузка...
Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours – implications for personalised cancer medicine
BACKGROUND: Response to EGFR-targeted therapies in colorectal cancer patients has been convincingly associated with Kirsten-Ras (K-Ras) mutation status. Current mandatory mutation testing for patient selection is limited to the K-Ras ‘hotspot’ codons 12 and 13. METHODS: Colorectal tumours (n=106) we...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2837563/ https://ncbi.nlm.nih.gov/pubmed/20147967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605534 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|